Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor

NCT02311088 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Too low enrolment rate

Conditions

Dyspnea

Interventions

DRUG: Caffeine
DRUG: Placebo

Sponsor

Uppsala University

Collaborators

[object Object]